Skip to Main Content

Paper Details

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.
Ann Oncol
2
2023
AM, AUS, CLL, Chronic lymphocytic leukemia, ICI, Patients, T-cell, advanced melanoma, chronic lymphocytic leukemia, leukemia, malignancies, melanoma, patients
Author NameAffiliation
Michael A DaviesUniversity of Texas MD Anderson Cancer Center
Michael A DaviesUniversity of Texas MD Anderson Cancer Center
Alexander J LazarUniversity of Texas MD Anderson Cancer Center
Sameer A ParikhMayo Clinic
Georgina V LongMelanoma Institute Australia, The University of Sydney, Sydney The University of Sydney Charles Perkins Centre, Sydney The University of Sydney Royal North Shore and Mater Hospitals
Jennifer A WargoUniversity of Texas MD Anderson Cancer Center
  • 1 - 6

Datasets

Release 1.2